Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.26 (
invertase
)
4,927
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Invertase formation in the yeast Saccharomyces cerevisiae is subject to repression by hexoses in the growth medium.
Mutagen
-induced (ethyl methanesulfonate or N-methyl-N-nitro-nitrosoguanidine)
invertase
hyperproducer mutants have been derived from the SUC3 MAL3 strain EK-6B by selecting for their ability to grow on media containing the sugar raffinose plus 2-deoxy-D-glucose (2DG). Raffinose like sucrose is a betta-fructoside which can be hydrolyzed by yeast
invertase
(beta-fructoside which can be hydrolyzed by yeast
invertase
(beta-fructofuranoside fructohydrolase). These mutants, designated dgr, produce higher levels of
invertase
(pi-glucosidase levels are also elevated but to a lesser extent) under conditions normally repressing
invertase
biosynthesis in the parent. Invertases of mutants dgr2 and dgr3 are indistinguishable from that of EK-6B with respect to their Km's for sucrose and thermal labilities. Genetic studies revealed that dgr2 and dgr3 are recessive and unlinked to the SUC3 gene.
...
PMID:Genetic control of invertase formation in Saccharomyces cerevisiae. II. Isolation and characterization of mutants conferring invertase hyperproduction in strain EK-6B carrying the SUC3 gene. 36 57